Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Clinical Trials01:16

Clinical Trials

6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.7K
Uncertainty: Overview00:59

Uncertainty: Overview

552
In analytical chemistry, we often perform repetitive measurements to detect and minimize inaccuracies caused by both determinate and indeterminate errors. Despite the cares we take, the presence of random errors means that repeated measurements almost never have exactly the same magnitude. The collective difference between these measurements - observed values - and the estimated or expected value is called uncertainty. Uncertainty is conventionally written after the estimated or expected value.
552
Interpretation of Confidence Intervals01:19

Interpretation of Confidence Intervals

5.7K
A confidence interval is a better estimate of the population than a point estimate, as it uses a range of values from a sample instead of a single value.
Confidence intervals have confidence coefficients that are crucial for their interpretation. The most common confidence coefficients are 0.90, 0.95, and 0.99, which can be written as percentages–90%, 95%, and 99%, respectively.
Suppose a person calculates a confidence interval with a confidence coefficient of 0.95. In that case, they can...
5.7K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Developing a practical Hospital Intravenous Therapy Quality Assessment Tool: Design, refinement, and feasibility.

The journal of vascular access·2026
Same author

Quantum-machine-assisted drug discovery.

npj drug discovery·2026
Same author

drGT: Interpretable Drug Response Prediction with Attention-Guided Gene Attribution on a Drug-Cell-Gene Heterogeneous Graph.

BMC bioinformatics·2026
Same author

Functional Analysis of <i>ZmABA8ox1b</i> in Regulating Maize Seed Germination via ABA Catabolism and Multi-Hormone Signaling Crosstalk.

Plants (Basel, Switzerland)·2026
Same author

Mitochondria-lysosome coupling contributes to lysosome acidification and aging.

Molecular cell·2026
Same author

Novel Hinokitiol-Based Ester/Sulfonate Derivatives Containing Diverse Heterocycles as Potential Fungicides and Nematicides.

Chemistry & biodiversity·2026

相关实验视频

Updated: Jun 28, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

对临床试验批准预测的不确定性量化和解释性.

Yingzhou Lu1, Tianyi Chen2, Nan Hao3

  • 1School of Medicine, Stanford University, Stanford, CA, USA.

Health data science
|April 22, 2024
PubMed
概括

这项研究引入了一种新的方法,通过量化不确定性和提高模型解释性来预测临床试验批准. 这提高了对药物开发和试验管理的资源配置.

更多相关视频

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

17.8K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K

相关实验视频

Last Updated: Jun 28, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

17.8K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K

科学领域:

  • * 计算生物学和生物信息学
  • * 医疗保健中的机器学习
  • * 制药研发领域的研究和开发.

背景情况:

  • * 临床试验对于新疗法开发至关重要,但却是昂贵且耗时的.
  • *准确的临床试验批准预测可以通过识别可能失败的试验来优化资源配置.
  • *现有的预测模型缺乏不确定性量化和解释性,限制了实际应用.

研究的目的:

  • * 量化不确定性并提高临床试验批准预测的可解释性.
  • * 提高临床试验管理中的预测模型的可靠性和实用性.
  • * 为了使药物开发资源的分配更好地进行决策.

主要方法:

  • * 选择性分类方法与层次交互网络模型的整合.
  • *利用不确定性量化方法,使模型能够避免低置信度预测.
  • * 开发一种模型,提高预测准确度并提供可解释性.

主要成果:

  • * 试验阶段的精度回忆曲线 (AUPRC) 下面面积显著改善:32.37% (第一阶段),21.43% (第二阶段) 和13.27% (第三阶段).
  • * 获得了AUPRC 0.9022分的第三阶段试验批准预测.
  • *通过案例研究证明了更好的模型解释性,有助于领域专家的理解.

结论:

  • * 拟议的方法有效地测量了临床试验结果预测中的模型不确定性.
  • * 纳入不确定性量化可以显著提高预测性能和可解释性.
  • *这种方法为优化临床试验管理和药物开发流程提供了有价值的工具.